Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Tax Rate (2020 - 2025)

X4 Pharmaceuticals filings provide 6 years of Tax Rate readings, the most recent being 0.1% for Q3 2025.

  • On a quarterly basis, Tax Rate rose 14.0% to 0.1% in Q3 2025 year-over-year; TTM through Dec 2025 was 0.05%, a 78.0% increase, with the full-year FY2025 number at 0.05%, up 78.0% from a year prior.
  • Tax Rate hit 0.1% in Q3 2025 for X4 Pharmaceuticals, up from 0.14% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 10.76% in Q1 2025 to a low of 1.14% in Q3 2023.
  • Median Tax Rate over the past 5 years was 0.03% (2021), compared with a mean of 0.44%.
  • Biggest five-year swings in Tax Rate: tumbled -120bps in 2023 and later skyrocketed 1080bps in 2025.
  • X4 Pharmaceuticals' Tax Rate stood at 0.01% in 2021, then crashed by -385bps to 0.05% in 2022, then crashed by -259bps to 0.17% in 2023, then crashed by -277bps to 0.65% in 2024, then skyrocketed by 115bps to 0.1% in 2025.
  • The last three reported values for Tax Rate were 0.1% (Q3 2025), 0.14% (Q2 2025), and 10.76% (Q1 2025) per Business Quant data.